About daphnecanada

This author has not yet filled in any details.
So far daphnecanada has created 7 blog entries.

TAKHZYRO: One Step Closer

2020-11-20T15:50:43-06:00

Amazing news! Canadian HAE patients are one step closer to gaining equitable access to the new treatment, TAKHZYRO! After months of negotiations, Takeda Canada announced it has completed negotiations with the pan Canadian Pharmaceutical Alliance (pCPA)

TAKHZYRO: One Step Closer2020-11-20T15:50:43-06:00

Terrific News for HAE Patients in Quebec

2020-08-12T07:27:46-06:00

We have some exciting news to share! We are pleased to let everyone know the Institut national d’excellence en santé et en services sociaux (INESSS) has reevaluated lanadelumab (Takhzyro) and soon HAE patients in Quebec

Terrific News for HAE Patients in Quebec2020-08-12T07:27:46-06:00

Canada Won the 2020 HAE Global Walk

2020-06-14T20:41:26-06:00

Thank you to the amazing HAE Community here in Canada - Canada won the Virtual 2020 HAE Global Walk; an annual event organized by the HAE International team. Many people from different parts of the

Canada Won the 2020 HAE Global Walk2020-06-14T20:41:26-06:00

2020-05-22T13:25:41-06:00

HAE Canada is excited to announce that our new and improved website officially went live today, May 22, 2020. This project was made possible through our partnership with HAE International (HAEi), which is graciously hosting

2020-05-22T13:25:41-06:00

Great News!

2020-05-20T15:36:22-06:00

HAEGARDA and TAKHZYRO are now available in Canada. Please talk to your HAE specialist about access. Thank you Canadian Blood Services (CBS) for a very collaborative, informative and team building HAE Forum. The care for

Great News!2020-05-20T15:36:22-06:00

HAE Day 2020

2020-05-20T07:37:08-06:00

For HAE Day 2020, HAE Canada wants to celebrate! To honour the day we have two BIG announcements: 1) Our website received a facelift! We hope our members find the updated content and new

HAE Day 20202020-05-20T07:37:08-06:00

HAEGARDA is available in Quebec

2020-05-20T11:42:03-06:00

We are thrilled to let the HAE community know that HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) is now available to HAE patients in Quebec. HAEGARDA is a subcutaneous C1 esterase inhibitor (C1-INH) therapy indicated for

HAEGARDA is available in Quebec2020-05-20T11:42:03-06:00
Go to Top